These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 9123539)

  • 21. Sequential combination therapy leads to biochemical and histological improvement despite low ongoing intrahepatic hepatitis B virus replication.
    Lutgehetmann M; Volzt T; Quaas A; Zankel M; Fischer C; Dandri M; Petersen J
    Antivir Ther; 2008; 13(1):57-66. PubMed ID: 18389899
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Tenofovir, An antiviral agent with activity against HIV infections and hepatitis B].
    Taéron C
    Rev Infirm; 2009 Sep; (153):49-51. PubMed ID: 19771814
    [No Abstract]   [Full Text] [Related]  

  • 23. [Current treatment of hepatitis B].
    Suárez García E; Romero Gómez M; Grande Santamaría L
    Gastroenterol Hepatol; 2001 Feb; 24 Suppl 1():35-50. PubMed ID: 11279893
    [No Abstract]   [Full Text] [Related]  

  • 24. Delivery of hepatitis B virus therapeutic agents using asialoglycoprotein receptor-based liver-specific targeting.
    Konishi M; Wu CH; Wu GY
    Methods Mol Med; 2004; 96():163-73. PubMed ID: 14762268
    [No Abstract]   [Full Text] [Related]  

  • 25. Future therapy for hepatitis B virus infection.
    Minami M
    Clin J Gastroenterol; 2015 Aug; 8(4):167-71. PubMed ID: 26265385
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Hepatological update (7). 2 different phases of chronic hepatitis B--2 different methods of treatment?].
    Juszczyk J
    Pol Tyg Lek; 1987 Oct; 42(43):1365-8. PubMed ID: 3328179
    [No Abstract]   [Full Text] [Related]  

  • 27. Design of new anti-viral agents for chronic hepatitis B virus infection.
    Locarnini S
    J Gastroenterol Hepatol; 1991; 6 Suppl 1():18-22. PubMed ID: 1751799
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel viral and host targets to cure hepatitis B.
    Ko C; Michler T; Protzer U
    Curr Opin Virol; 2017 Jun; 24():38-45. PubMed ID: 28433762
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antiviral effect of Curcuma longa Linn extract against hepatitis B virus replication.
    Kim HJ; Yoo HS; Kim JC; Park CS; Choi MS; Kim M; Choi H; Min JS; Kim YS; Yoon SW; Ahn JK
    J Ethnopharmacol; 2009 Jul; 124(2):189-96. PubMed ID: 19409970
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Viral hepatitis: towards the eradication of HCV and a cure for HBV.
    Asselah T; Marcellin P
    Liver Int; 2015 Jan; 35 Suppl 1():1-3. PubMed ID: 25529080
    [No Abstract]   [Full Text] [Related]  

  • 31. Management of hepatitis B virus infection during treatment for hepatitis B virus-related hepatocellular carcinoma.
    Kubo S; Takemura S; Tanaka S; Shinkawa H; Nishioka T; Nozawa A; Kinoshita M; Hamano G; Ito T; Urata Y
    World J Gastroenterol; 2015 Jul; 21(27):8249-55. PubMed ID: 26217076
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dynamics of hepatitis B virus infection.
    Ribeiro RM; Lo A; Perelson AS
    Microbes Infect; 2002 Jul; 4(8):829-35. PubMed ID: 12270730
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of immunosuppressive and antiviral agents on hepatitis B virus replication in vitro.
    McMillan JS; Shaw T; Angus PW; Locarnini SA
    Hepatology; 1995 Jul; 22(1):36-43. PubMed ID: 7601429
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Good results of lamivudine in hepatitis B surface antigen-positive patients with active viral replication before liver transplantation.
    Gugenheim J; Baldini E; Ouzan D; Sowka P; Mouiel J
    Transplant Proc; 1999; 31(1-2):554-5. PubMed ID: 10083234
    [No Abstract]   [Full Text] [Related]  

  • 35. Efficacy and safety of lamivudine on replication of recurrent hepatitis B after cadaveric renal transplantation.
    Rostaing L; Henry S; Cisterne JM; Duffaut M; Icart J; Durand D
    Transplantation; 1997 Dec; 64(11):1624-7. PubMed ID: 9415572
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Reappraisal of different therapeutic strategies for combating hepatitis B].
    Si CW
    Zhonghua Nei Ke Za Zhi; 2003 Jun; 42(6):363-4. PubMed ID: 14509982
    [No Abstract]   [Full Text] [Related]  

  • 37. Antiviral activity of ganciclovir, 9-(1,3-dihydroxy-2-propoxymethyl) guanine against woodchuck hepatitis virus: quantitative measurement of woodchuck hepatitis virus DNA using storage phosphor technology.
    Zahm FE; Bonino F; Giuseppetti R; Rapicetta M
    Ital J Gastroenterol Hepatol; 1998 Oct; 30(5):510-6. PubMed ID: 9836108
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antiviral treatment of chronic type B hepatitis.
    Hoofnagle JH
    Ann Intern Med; 1987 Sep; 107(3):414-5. PubMed ID: 2441635
    [No Abstract]   [Full Text] [Related]  

  • 39. Efficacy of lamivudine in patients with hepatitis B virus precore mutant infection before and after liver transplantation.
    Ben-Ari Z; Zemel R; Kazetsker A; Fraser G; Tur-Kaspa R
    Am J Gastroenterol; 1999 Mar; 94(3):663-7. PubMed ID: 10086648
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Follow-Up Study on the Renal Protective Efficacy of Telbivudine for Hepatitis B Virus-Infected Taiwanese Patients After Living Donor Liver Transplant.
    Lin KH; Chen YL; Lin PY; Hsieh CE; Ko CJ; Lin CC; Ming YZ
    Exp Clin Transplant; 2017 Feb; 15(1):65-68. PubMed ID: 28004999
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.